VICTOR spoiled?

J Clin Oncol. 2010 Oct 20;28(30):4546-8. doi: 10.1200/JCO.2010.31.6653. Epub 2010 Sep 13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Chemotherapy, Adjuvant
  • Clinical Trials, Phase III as Topic
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / enzymology
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / surgery
  • Cyclooxygenase 2 / analysis
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Disease-Free Survival
  • Early Termination of Clinical Trials
  • Evidence-Based Medicine
  • Humans
  • Lactones / adverse effects
  • Lactones / therapeutic use*
  • Multicenter Studies as Topic
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Safety-Based Drug Withdrawals
  • Sulfones / adverse effects
  • Sulfones / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human